EPHB2 and neoplasm: The expression levels of LGR5, EPHB2, CD44s and CD44v6 were increased at least 2-fold in 70.8% (34/48), 72.0% (36/50), 66.0% (33/50) and 86.0% (43/50) of tumour tissues compared to matched normal tissues (Fig 1).